Medically reviewed by Lauren Schlanger, MD Key Takeways Anal herpes is caused by the herpes simplex virus, usually spread ...

Ruvidar(TM) demonstrates higher efficacy in the treatment of Herpes Simplex Virus, Type 1 versus FDA-approved, standard of care treatments Acyclovir and Abreva in a preclinical animal model. In the ...

Innovative Molecules' adibelivir had a favourable pharmacokinetic profile and proved safe and efficacious in Phase I clinical ...

Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that will make you thankful for the existence of herpes and other viruses.

Researchers at Fred Hutch Cancer Center have found in pre-clinical studies that an experimental gene therapy for genital and oral herpes removed 90% or more of the infection and suppressed how much ...

A small square device made of plexiglass, which could fit in the palm of your hand, has shown promise as a model of human disease that could speed research for treatments for herpes and other ...

– ABI-5366 is currently being evaluated in ongoing Phase 1b clinical trial with interim proof-of-concept data expected in fall 2025 – SOUTH SAN FRANCISCO, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- ...

Aicuris’s pritelivir is forecast to be a significant advancement for immunocompromised patients with refractory HSV infections.

Future Microbiol. 2010;5(1):15-22. The ocular and genital mucosa are key players in regulation of herpes simplex virus (HSV) susceptibility and recurrent disease. Prophylactic and therapeutic ...

Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model. TORONTO, ON / ...

Herpes has been called “the gift that keeps on giving” — finally, its presence has come in handy. Roughly two-thirds of the global population has been infected with herpes simplex virus type 1 (HSV-1) ...